Julian Mackay-Wiggan
Clinical Professor, Ronald O. Perelman Department of Dermatology · NYU Grossman School of Medicine
Credentials: · · · · · ·
History
Research
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Nature Medicine · 2014 · 760 citations
Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome
New England Journal of Medicine · 2012 · 436 citations
Systematic review or meta-analysis · Nature Communications · 2015 · 233 citations
- RC
10 papers
7 papers · 1 as a resident
5 papers
5 papers
4 papers
4 papers
- EE
4 papers
4 papers · 2 as a resident
Grants
- 2016–2023
Alopecia Areata Center for Research Translation (AACORT)
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P50
Project lead · $1.6M · Columbia University Health Sciences
- 2016–2022
Columbia University Skin Disease Resource-Based Center (epiCURE)
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P30
Project lead · $978.3K · Columbia University Health Sciences
Clinical trials
- 2015–2017
Principal investigator · Completed · Phase 2
Columbia University
- 2013–2017
Principal investigator · Completed · Phase 2
Columbia University
- 2013–2016
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
Principal investigator · Completed · Phase 2
Columbia University
- 2013–2016
A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
Principal investigator · Withdrawn · Phase 2
Columbia University